Recombinant multi-species ELAVL4/ELVAL4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ELAVL4/ELVAL4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Enables mRNA 3'-UTR AU-rich region binding activity; poly(A) binding activity; and pre-mRNA intronic pyrimidine-rich binding activity. Involved in 3'-UTR-mediated mRNA stabilization; RNA processing; and positive regulation of 3'-UTR-mediated mRNA stabilization. Predicted to be located in axon; cytoplasm; and dendrite. Predicted to be part of polysomal ribosome. Predicted to be active in glutamatergic synapse. [provided by Alliance of Genome Resources, Apr 2022]
The Alternative Names of target: ELAVL4, ELVAL4,ELAV-like protein 4,Hu-antigen D (HuD), Paraneoplastic encephalomyelitis antigen HuD,HUD,PNEM

Target products collectionGo to ELAVL4/ELVAL4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IO037-Ab-1/ GM-Tg-hg-IO037-Ab-2 Human ELAVL4/ELVAL4 protein Human
GM-Tg-rg-IO037-Ab-1/ GM-Tg-rg-IO037-Ab-2 Rat ELAVL4/ELVAL4 protein Rat
GM-Tg-mg-IO037-Ab-1/ GM-Tg-mg-IO037-Ab-2 Mouse ELAVL4/ELVAL4 protein Mouse
GM-Tg-cynog-IO037-Ab-1/ GM-Tg-cynog-IO037-Ab-2 Cynomolgus/Rhesus macaque ELAVL4/ELVAL4 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-IO037-Ab-1/ GM-Tg-felg-IO037-Ab-2 Feline ELAVL4/ELVAL4 protein Feline
GM-Tg-cang-IO037-Ab-1/ GM-Tg-cang-IO037-Ab-2 Canine ELAVL4/ELVAL4 protein Canine
GM-Tg-bovg-IO037-Ab-1/ GM-Tg-bovg-IO037-Ab-2 Bovine ELAVL4/ELVAL4 protein Bovine
GM-Tg-equg-IO037-Ab-1/ GM-Tg-equg-IO037-Ab-2 Equine ELAVL4/ELVAL4 protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IO037-Ab-1/ GM-Tg-hg-IO037-Ab-2; GM-Tg-rg-IO037-Ab-1/ GM-Tg-rg-IO037-Ab-2;
GM-Tg-mg-IO037-Ab-1/ GM-Tg-mg-IO037-Ab-2; GM-Tg-cynog-IO037-Ab-1/ GM-Tg-cynog-IO037-Ab-2;
GM-Tg-felg-IO037-Ab-1/ GM-Tg-felg-IO037-Ab-2; GM-Tg-cang-IO037-Ab-1/ GM-Tg-cang-IO037-Ab-2;
GM-Tg-bovg-IO037-Ab-1/ GM-Tg-bovg-IO037-Ab-2; GM-Tg-equg-IO037-Ab-1/ GM-Tg-equg-IO037-Ab-2
Products Name ELAVL4/ELVAL4 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ELAVL4/ELVAL4
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ELAVL4/ELVAL4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.